Novo seeks to expand India portfolio with new tech investments
By United One News · AI-generated summary of 1 outlets' reporting
Published
AI-generated summary of the coverage listed below: Novo, the maker of Ozempic and Wegovy, is investing in new technologies to broaden its offerings in India. The company is exploring different platforms to develop personalized treatments for diabetes and obesity.
Covered by 1 outlet across the spectrum: 0% left, 100% center, 0% right.
How each side framed it
Ozempic & Wegovy maker Novo looks to expand India portfolio through investments in new technologies
Timeline
First reported by The Hindu BusinessLine on ; 1 article from 1 outlets so far.
Who is covering this story
- Center (1): The Hindu BusinessLine